Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypertension

Free Subscription 14.09.2026 1 Am Heart J 4 Am J Hypertens 2 Circ Heart Fail 2 Clin Exp Hypertens 1 Dtsch Med Wochenschr 3 Eur Heart J 1 Eur J Pharmacol 1 Hypertension 1 J Am Coll Cardiol 4 J Hum Hypertens 1 J Hypertens 1 PLoS Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. SANTO K, Martins E, Silva GS, Guimaraes PO, et al
   Intensive Blood-Pressure Control for the Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes: Rationale, Design and Baseline Characteristics of the OPTIMAL-DIABETES Randomized Trial.
   Am Heart J. 2026 Jul 24:107545. doi: 10.1016/j.ahj.2026.107545.
   PubMed         Abstract available
   
   

   
   Am J Hypertens

2. FAN L, Xiong C, Qi X
   MiR-23b-3p exerts a protective effect in hypertensive nephropathy by inhibiting fibrosis and inflammation.
   Am J Hypertens. 2026 Sep 11:hpag108. doi: 10.1093.
   PubMed         Abstract available
   
   
3. GRIFFIN KA, Priviero FBM, McCarthy CG, Mills KT, et al
   Hypertension Summer School Sponsored by American Journal of Hypertension, July 25-29, 2024, Loyola University, Chicago, Illinois.
   Am J Hypertens. 2026 Sep 10:hpag106. doi: 10.1093.
   PubMed        
   
   
4. SRIPERUMBUDURI S, Khan RW, Aftab S, Hiremath S, et al
   Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways.
   Am J Hypertens. 2026 Sep 8:hpag111. doi: 10.1093.
   PubMed         Abstract available
   
   
5. TOMITANI N, Morimoto T, Harada N, Hoshide S, et al
   Associations of Program Adherence and Motivation with Blood Pressure Reduction in a Digital Therapeutic for Hypertension: The B-INDEX Study.
   Am J Hypertens. 2026 Sep 8:hpag107. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

6. ALOTAIBI M, Tang A, Sun N, Gurholt I, et al
   Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension.
   Circ Heart Fail. 2026 Sep 10:e014073. doi: 10.1161/CIRCHEARTFAILURE.125.014073.
   PubMed         Abstract available
   
   
7. GARRY JD, Brittain EL
   Disentangling Pulmonary Vascular Phenotypes in Group 2 Pulmonary Hypertension Using Bioactive Lipid Profiling.
   Circ Heart Fail. 2026 Sep 10:e014894. doi: 10.1161/CIRCHEARTFAILURE.126.014894.
   PubMed        
   
   

   
   Clin Exp Hypertens

8. PANG J, Xia K, Ma Y
   Electroacupuncture in hypertension-mediated organ damage: A hypothesis-generating framework of blood pressure-dependent and candidate blood pressure-independent mechanisms.
   Clin Exp Hypertens. 2026;48:2728373.
   PubMed         Abstract available
   
   
9. WU Y, Fang F
   Associations of antihypertensive medication class with liver fibrosis and mortality in US adults with MASLD.
   Clin Exp Hypertens. 2026;48:2725928.
   PubMed         Abstract available
   
   

   
   Dtsch Med Wochenschr

10. KLOSE H, Roitenberg A, Kronberg K
    Factors influencing treatment decisions in patients with pulmonary arterial hypertension.
    Dtsch Med Wochenschr. 2026 Sep 9. doi: 10.1055/a-2893-7266.
    PubMed         Abstract available
    
    

    
    Eur Heart J

11. 
    Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model.
    Eur Heart J. 2026 Mar 11:ehag154. doi: 10.1093.
    PubMed         Abstract available
    
    
12. NAMAJIMA T, Ushijima R, Tanaka R
    Novel oblique dynamic chest radiography for retrocardiac pulmonary blood flow imaging in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2026 Sep 7:ehag711. doi: 10.1093.
    PubMed        
    
    
13. 
    Correction to: Quadruple vs triple therapy for resistant hypertension: the QUADRO trial.
    Eur Heart J. 2026 Sep 8:ehag758. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Pharmacol

14. BLASCKE DE MELLO MM, de Oliveira RR, Gomes BQ, Dourado TMH, et al
    Developmental exposure to resveratrol induces context-dependent vascular effects in adult offspring: protection in SHR and adverse remodeling in normotensive rats.
    Eur J Pharmacol. 2026;1033:179272.
    PubMed         Abstract available
    
    

    
    Hypertension

15. MAO Y, Jiang Y, Wu T, Li P, et al
    Revealing Causal Proteomic Signatures of Hypertension: Systematic Insights From Proteome-Wide Mendelian Randomization.
    Hypertension. 2026 Sep 9. doi: 10.1161/HYPERTENSIONAHA.126.26937.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

16. MISRA A, Jowell A, Haidermota S, Perez E, et al
    Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions.
    J Am Coll Cardiol. 2026 Apr 29:S0735-1097(26)05809.
    PubMed         Abstract available
    
    

    
    J Hum Hypertens

17. MCCLINTICK DJ, Bowman HC, Ebinger JE
    Too much, too soon? The argument against initial combination therapy in stage I hypertension.
    J Hum Hypertens. 2026 Sep 11. doi: 10.1038/s41371-026-01221.
    PubMed        
    
    
18. SEARLE D, Andersen EW, Aarestrup J, Baker JL, et al
    Childhood BMI trajectories and hypertension in adulthood: a population-based cohort study.
    J Hum Hypertens. 2026 Sep 4. doi: 10.1038/s41371-026-01219.
    PubMed         Abstract available
    
    
19. BALTHAZAAR SJT, Walter M, Jutzeler CR, Maharaj AL, et al
    Blood pressure variability in daily life: comparing individuals with cervical and upper-thoracic spinal cord injury to non-injured controls.
    J Hum Hypertens. 2026;40:712-723.
    PubMed         Abstract available
    
    
20. LEE EK, Wang S, Ng CS, Wong S, et al
    Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.
    J Hum Hypertens. 2026;40:689-701.
    PubMed         Abstract available
    
    

    
    J Hypertens

21. HUTTL M, Miklovic M, Skaroupkova P, Vanourkova Z, et al
    Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME.
    J Hypertens. 2026 Aug 13. doi: 10.1097/HJH.0000000000004422.
    PubMed         Abstract available
    
    

    
    PLoS Med

22. GUMEDE SB, Manne-Goehler J, Kelechi Oladimeji E, Bulled N, et al
    The longitudinal care cascade for hypertension in people with and without HIV in South Africa: A clinic-based observational study.
    PLoS Med. 2026;23:e1004957.
    PubMed         Abstract available
    
    

    
    PLoS One

23. CHEN KT, Yen ET, Tsai KZ, Lin SY, et al
    Screen-detected raised blood pressure and gaps in the hypertension care cascade among adults attending a humanitarian medical mission in Ukraine: A cross-sectional study.
    PLoS One. 2026;21:e0357957.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum